Cherry Hughes** is an active, energetic 75 year old, still working in the marketing and public relations profession in Great Britain. Her life is filled with friends and fun. “I love cooking and eating out. I am deeply interested in politics. I love music …I go to jazz clubs. I love going to France …I have a little apartment...
Read More
There are 1.6 million people diagnosed with cancer in the US each year. Of these, 650,000 receive chemotherapy. Did you know that 60,000 people a year are hospitalized for neutropenia, a common side effect of chemotherapy? One in fourteen die because of it. Of the 650,000 receiving chemotherapy, 104,000 are not aware of neutropenia and 52,000 don’t...
Read MoreIn a nutshell This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. Some background Post-traumatic stress disorder (PTSD) is a...
Read MoreIn a nutshell This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. Some background Post-traumatic stress disorder (PTSD) is a...
Read MoreIn a nutshell This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. Some background Post-traumatic stress disorder (PTSD) is a...
Read More
After three hurricanes, flooding, fires and mudslides, and now severe cold and snow in the Deep South and throughout the country, the US has had its share of emergencies. Are you prepared? For people who rely on oxygen, who are on dialysis, have diabetes or other serious conditions, it is time to think about putting together some of the essentials. What...
Read More
In a nutshell This study determined the outcomes of early-stage classical Hodgkin’s lymphoma (HL) patients who received ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy and radiotherapy (RT) only. The study concluded that patients who showed a good partial response (tumor shrinkage) to ABVD chemotherapy were successfully...
Read More
In a nutshell This study looked at the combination of brentuximab vedotin (Adcetris) and nivolumab (Opdivo) to treat patients with relapsed or difficult to treat Hodgkin lymphoma. The study concluded that the combination of brentuximab vedotin and nivolumab is an effective treatment for patients with relapsed Hodgkin lymphoma. Some...
Read More
In a nutshell This study analyzed the long-term effects of cancer on sleep quality and health-related quality of life (HRQOL) in 9-year NHL and HL survivors. The study concluded that poor sleep is associated with poor HRQOL. Some background Improvements in detecting and treating cancer have led to declining mortality rates. As the number of cancer...
Read More
In a nutshell This study analyzed the long-term effects of cancer on sleep quality and health-related quality of life (HRQOL) in 9-year NHL and HL survivors. The study concluded that poor sleep is associated with poor HRQOL. Some background Improvements in detecting and treating cancer have led to declining mortality rates. As the number of cancer...
Read More
In a nutshell This study determined the safety and effectiveness of combined brentuximab vedotin (Adcetris) and bendamustine (Treanda) for relapsed or refractory (did not respond to treatment) Hodgkin’s lymphoma (HL). The study concluded that this combination is safe and effective, even for patients who already received intense anticancer...
Read More
It has taken decades of work for researchers to find ways to activate the immune system to treat cancer (what we now call immuno-oncology or I-O). Much of that work has been poorly funded. Largely, it has been the result of researchers getting experience in other disciplines (like infectious disease) and then transferring that expertise to oncology...
Read More
